Insights, clinical perspective, and honest conversation from the MedBridge Global faculty - on peptides, regenerative medicine, and practicing at the standard the science deserves.
MedBridge Global Medical Director Dr Baback Amen delivered the keynote Beyond Longevity: Precision Healthspan Design and the Medicine of the Future at a Therme Future event in Dubai.
Washington State University's Alphatide, a peptide designed to block sperm development, has a $274,849 grant to finish preclinical work before an FDA application for human trials. A summary of the WSU report and the MedBridge Global team's view.
HHS will temporarily let compounding pharmacies supply BPC-157, TB-500, epitalon, MOTS-c, KPV and semax by prescription. A summary of the ABC News report, the conditions attached and the MedBridge Global team's view for prescribers.
A hospitalisation after a gray-market sermorelin injection, contaminated samples and FDA warning letters: a summary of the latest concerns about unregulated peptides, and what they mean for clinicians.
ACOG has published its most comprehensive menopause guidance to date, covering hot flashes, night sweats, sleep and mood. A summary of what changed for clinicians, with links to the source.
The FDA convened a workshop on testosterone therapy in menopausal women, where one UK clinic's real-world data took center stage. Here's what clinicians should take from it.
Nate Hill of Strive Pharmacy on FDA Category 1, GMP-vetted API sourcing, and how compounding pharmacies are preparing for the next phase of peptide regulation.
On bandwagons, MLM energy, "not for human use" experts, and the incredibly powerful science that deserves better than what social media is doing to it.